 |
bevacizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Hereditary hemorrhagic telangiectasia |
| USA Market Approval | USA |
| USA Designation Date | 2010-10-21 00:00:00 |
| Sponsor | Terence M. Davidson, MD;UCSD Medical Center;San Diego, California, 92103 |
| |
bevacizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Hereditary hemorrhagic telangiectasia |
| USA Market Approval | USA |
| USA Designation Date | 2010-10-21 00:00:00 |
| Sponsor | Terence M. Davidson, MD;UCSD Medical Center;San Diego, California, 92103 |